Studies on slow release antibiotic middle ear pellets
Publication Date
July 19, 2019
Creator
Abstract
Otitis Media with Effusion (OME) is the commonest cause of paediatric hearing impairment globally. Antibiotic laden pellets placed in the middle ear (ME) present a potential novel treatment strategy for OME disrupting the middle ear biofilm and avoiding systemic side effects. In vitro studies of Staphylococcus Aureus biofilm eradication with pellets laden with rifampicin and clindamycin demonstrate a future potential OME treatment and this study aims to establish the safety of these pellets in vivo.
Rifampicin (1.8mM) and clindamycin (35.3mM) loaded pellets made of poly lactic-co-glycolic acid and pluronic were surgically placed in guinea pig middle ears.
Auditory Brainstem Responses (ABRs) thresholds between 8-30 kHz were tested over 16 weeks alongside controls to assess for ototoxicity; amplitudes and latencies studied to assess for neurotoxicity. At one week post insertion of antibiotic laden pellets, marked ABR threshold elevation (15-40 dB) was observed and persisted (25-40 dB) at week 16 without accompanying changes in ABR wave amplitudes and latencies. This pattern therefore does not support a neurotoxic mechanism.
Representative cytocochleograms and immunofluorescence of the cochleas did not exhibit any appreciable frank outer or inner hair cell loss from the guinea pigs loaded with rifampicin and clindamycin pellets. This suggests that the pellets are not causing threshold elevation via an ototoxic mechanism.
ME histology revealed pellet remnants causing a moderate inflammatory response persisting at 16 weeks. With evidence of chronic inflammation in the middle ear, an associated ME effusion which has been undetected experimentally may underlie the ABR threshold elevation seen with rifampicin and clindamycin laden pellets. Confined to the middle ear, this may also explain the lack of IHC and OHC damage.
As a delivery vehicle to the ME, PLGA and Pluronic pellets have potential, but further studies are required on their antibiotic carriage to the middle ear before in vivo use.
Item Type
ethesis
Thesis Type
PhD
Supervisors
Keywords
Subjects (LC)
Associated Schools / Departments
School of Medicine
eprints ID
56413
UoN Repository URI
Except where otherwise noted, this item's license is described as
File(s)![Thumbnail Image]()
Name
Thesis post corrections clean.pdf
Type
Full-text
Description
Examined
Size
8.16 MB
Format
Adobe PDF
Checksum (MD5)
bde14dbf50ba2d15e3293c323e1d6298